PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cleveland Clinic-led research supports repurposing sildenafil (Viagra) for Alzheimer’s treatment

Large-scale study provides evidence that FDA-approved drug can help protect brain cells from Alzheimer’s disease

Cleveland Clinic-led research supports repurposing sildenafil (Viagra) for Alzheimer’s treatment
2024-03-05
(Press-News.org) CLEVELAND – New Cleveland Clinic-led research points to sildenafil (Viagra) as a potential treatment for Alzheimer’s disease. The study provides evidence from computational models, insurance claims data and observations from brain cells in Alzheimer’s patients.  

Sildenafil is the main component of drugs used to treat erectile dysfunction (Viagra) and pulmonary arterial hypertension (Revatio).

“Our findings provide further weight to re-purposing this existing FDA-approved drug as a novel treatment for Alzheimer’s, which is in great need of new therapies,” said Feixiong Cheng, Ph.D., who led the research. “We used artificial intelligence to integrate data across multiple domains which all indicated sildenafil’s potential against this devastating neurological disease.”

Alzheimer’s disease currently affects over 6 million Americans and incidence is expected to triple by 2050, underscoring the need for rapid development of new prevention and treatment strategies. Drug repurposing – use of an existing drug for new therapeutic purposes – offers a practical alternative to the costly and time-consuming traditional drug discovery process.

Published in Journal of Alzheimer’s Disease, the study builds upon the researchers’ earlier findings in 2021 that used computational models to initially identify sildenafil as a promising drug candidate to help prevent and treat Alzheimer’s disease.

In the new study, Dr. Cheng, director of the  Cleveland Clinic Genome Center, and his team analyzed millions of de-identified insurance claims from two independent patient databases, which revealed a 30-54% reduced prevalence in Alzheimer’s disease diagnoses among patients who took sildenafil compared to those who did not after adjusting various possible confounding factors.

In brain cells from Alzheimer’s patients, researchers also showed that sildenafil lowers levels of neurotoxic tau proteins, which are known to be associated with Alzheimer’s disease when they build up. They also found that neurons treated with sildenafil expressed genes related to cell growth, improved brain function, reduced inflammation and other processes known to protect against the neural degeneration associated with Alzheimer’s disease.

Dr. Cheng’s findings demonstrate the feasibility of using computer models to identify potential new drug candidates in a fast, reliable way, representing a significant step forward in Alzheimer’s drug discovery.

“After integrating this large amount of data computationally, it is rewarding to see sildenafil’s effects in human neurons and real-world patient outcomes,” said Dr. Cheng. “We believe our findings provide the evidence needed for clinical trials to further examine the potential effectiveness of sildenafil in patients with Alzheimer’s disease.”

Dr. Cheng’s co-authors include Andrew A. Pieper, M.D., Ph.D., of Louis Stokes Cleveland VA Medical Center, Case Western Reserve University and University Hospitals Cleveland Medical Center; and Jeffrey Cummings, M.D., Sc.D., director emeritus of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas.

Dhruv Gohel, Ph.D., and Amit Gupta, Ph.D., postdoctoral research associates in Dr. Cheng’s laboratory, are co-first authors. The study was primarily supported by the National Institute on Aging of the National Institutes of Health (NIH) under award numbers R01AG066707, U01AG073323, R01AG076448, R01AG082118, RF1AG082211, R01AG084250, R56AG074001, andR21AG083003, and the National Institute of Neurological Disorders and Stroke of NIH under award number RF1NS133812.

CLEVELAND – New Cleveland Clinic-led research points to sildenafil (Viagra) as a potential treatment for Alzheimer’s disease. The study provides evidence from computational models, insurance claims data and observations from brain cells in Alzheimer’s patients.  

Sildenafil is the main component of drugs used to treat erectile dysfunction (Viagra) and pulmonary arterial hypertension (Revatio).

“Our findings provide further weight to re-purposing this existing FDA-approved drug as a novel treatment for Alzheimer’s, which is in great need of new therapies,” said Feixiong Cheng, Ph.D., who led the research. “We used artificial intelligence to integrate data across multiple domains which all indicated sildenafil’s potential against this devastating neurological disease.”

Alzheimer’s disease currently affects over 6 million Americans and incidence is expected to triple by 2050, underscoring the need for rapid development of new prevention and treatment strategies. Drug repurposing – use of an existing drug for new therapeutic purposes – offers a practical alternative to the costly and time-consuming traditional drug discovery process.

Published in Journal of Alzheimer’s Disease, the study builds upon the researchers’ earlier findings in 2021 that used computational models to initially identify sildenafil as a promising drug candidate to help prevent and treat Alzheimer’s disease.

In the new study, Dr. Cheng, director of the  Cleveland Clinic Genome Center, and his team analyzed millions of de-identified insurance claims from two independent patient databases, which revealed a 30-54% reduced prevalence in Alzheimer’s disease diagnoses among patients who took sildenafil compared to those who did not after adjusting various possible confounding factors.

In brain cells from Alzheimer’s patients, researchers also showed that sildenafil lowers levels of neurotoxic tau proteins, which are known to be associated with Alzheimer’s disease when they build up. They also found that neurons treated with sildenafil expressed genes related to cell growth, improved brain function, reduced inflammation and other processes known to protect against the neural degeneration associated with Alzheimer’s disease.

Dr. Cheng’s findings demonstrate the feasibility of using computer models to identify potential new drug candidates in a fast, reliable way, representing a significant step forward in Alzheimer’s drug discovery.

“After integrating this large amount of data computationally, it is rewarding to see sildenafil’s effects in human neurons and real-world patient outcomes,” said Dr. Cheng. “We believe our findings provide the evidence needed for clinical trials to further examine the potential effectiveness of sildenafil in patients with Alzheimer’s disease.”

Dr. Cheng’s co-authors include Andrew A. Pieper, M.D., Ph.D., of Louis Stokes Cleveland VA Medical Center, Case Western Reserve University and University Hospitals Cleveland Medical Center; and Jeffrey Cummings, M.D., Sc.D., director emeritus of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas.

Dhruv Gohel, Ph.D., and Amit Gupta, Ph.D., postdoctoral research associates in Dr. Cheng’s laboratory, are co-first authors. The study was primarily supported by the National Institute on Aging of the National Institutes of Health (NIH) under award numbers R01AG066707, U01AG073323, R01AG076448, R01AG082118, RF1AG082211, R01AG084250, R56AG074001, andR21AG083003, and the National Institute of Neurological Disorders and Stroke of NIH under award number RF1NS133812.

END

[Attachments] See images for this press release:
Cleveland Clinic-led research supports repurposing sildenafil (Viagra) for Alzheimer’s treatment

ELSE PRESS RELEASES FROM THIS DATE:

Antarctic researchers hitched a lift on a cruise ship, and recommend this eco-friendly, collaborative approach to remote ocean science

Antarctic researchers hitched a lift on a cruise ship, and recommend this eco-friendly, collaborative approach to remote ocean science
2024-03-05
Antarctic researchers hitched a lift on a cruise ship, and recommend this eco-friendly, collaborative approach to remote ocean science.  #### Article URL: https://journals.plos.org/climate/article?id=10.1371/journal.pclm.0000348 Article Title: New methods of undertaking marine science in Antarctica using tourism vessels Contact:  Matthew Mulrennan; matt@kolossal.org Author Countries: Canada, United States Funding: The authors received no specific funding for this work. END ...

Odysseus has a new home and brings the Earthling Project along for the ride

Odysseus has a new home and brings the Earthling Project along for the ride
2024-03-05
March 5, 2024, Mountain View, CA – The moon lander Odysseus, known as Odie, touched down on the Moon's surface on February 22, becoming the first time the U.S. has landed on the Moon in more than 50 years and the first commercial moon lander to successfully land on the Moon. Along with its science payload, the spacecraft also brought along a fusion of art and space exploration, SETI Institute's Artist in Residence (SETI AIR), Felipe Pérez Santiago's Earthling Project, a collection of global musical compositions representing Earth's cultural ...

Painting a molecular portrait of the brain with mass spectrometry and deep learning

Painting a molecular portrait of the brain with mass spectrometry and deep learning
2024-03-05
Beckman Institute for Advanced Science and Technology researchers Jonathan Sweedler, a professor of chemistry, and Fan Lam, a professor of bioengineering, outlined how spatial omics technologies can reveal the molecular intricacy of the brain at different scales. Their research appeared this month in Nature Methods. The researchers and their colleagues used a biochemical imaging framework integrated with deep learning to create 3D molecular maps with cell specificity to better understand how the brain functions in health and disease. Their research is supported by a $3 million grant from ...

Semaglutide reduces severity of common liver disease in people with HIV

Semaglutide reduces severity of common liver disease in people with HIV
2024-03-05
WHAT: A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver. This is the first clinical trial of semaglutide for MASLD in people with HIV. The research was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and conducted in the United States and Brazil by ACTG, a global clinical trials network focused on HIV and other infectious diseases. ...

The Lancet: Experts warn about the overmedicalisation of menopause and call for a new approach to how society views menopause and supports women as they age

The Lancet: Experts warn about the overmedicalisation of menopause and call for a new approach to how society views menopause and supports women as they age
2024-03-05
The Lancet: Experts warn about the overmedicalisation of menopause and call for a new approach to how society views menopause and supports women as they age Menopause is a life stage for half the world’s population and is generally depicted in a negative way. However, women’s experiences of menopause are unique and vary hugely.  The Lancet 2024 Series on menopause argues that an over-simplified narrative of menopause as a health problem to be solved by replacing hormones is not based on evidence and deflects attention from the need for substantial societal shifts in how menopause, and midlife/older women in general, are viewed and treated around the world. The ...

Researchers show that menopause does not always impact mental health

Researchers show that menopause does not always impact mental health
2024-03-05
A new review paper from authors at Brigham and Women’s Hospital and collaborators concludes that menopause does not uniformly elevate the risk of depression and other mental health conditions. Menopause has long been thought to cause psychological distress, but a new review suggests that this is not always the case. The review, written by experts from Brigham Women’s Hospital, a founding member of the Mass General Brigham healthcare system, and international collaborators, is the third in a series of menopause-themed papers published in The ...

Evolving hydrogen-storage technology: guidelines developed for the design of anti-evaporation catalysts

2024-03-05
1. A research team consisting of NIMS and the Tokyo Institute of Technology has identified materials capable of catalyzing the conversion of ortho-hydrogen to para-hydrogen. These catalysts should be essential to the spread of mass-transportation/storage of liquid hydrogen. 2. Hydrogen is becoming widely accepted as an alternative energy source to fossil fuels. Its liquefaction (at temperatures below -253°C under pressures higher than one atmosphere) can dramatically reduce its volume, making it suitable for transportation and storage. Hydrogen molecules (H2)—each composed of two hydrogen atoms—exist in two isomeric forms: ortho- and para-H2. Under normal conditions, ...

Early retirement impacts mental health of blue-collar women more than white-collar peers

2024-03-05
Retirement is a major transition that can have a significant impact on a person’s life. For some, retirement evokes thoughts of slowing down, relaxing, and enjoying more of what life has to offer. For others, ending a regular work schedule can create stress and uncertainties about being able to pay necessary bills and maintain adequate medical care. A new study by researchers at the Yale School of Public Health examines how retirement affects mental health and related inpatient mental health care among female workers in China, ...

A smart molecule beats the mutation behind most pancreatic cancer

2024-03-05
FOR IMMEDIATE RELEASE Media Contact: LEVI GADYE (628) 399-1046 Levi.Gadye@ucsf.edu  Subscribe to UCSF News A Smart Molecule Beats the Mutation Behind Most Pancreatic Cancer  Scientists discover a new way to disarm a deadly protein that also appears in cancers of the lung, breast and colon. UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition. The new molecule permanently modifies a wily cancer-causing ...

Using light to precisely control single-molecule devices

Using light to precisely control single-molecule devices
2024-03-05
In a new Nature Communications study, Columbia Engineering researchers report that they have built highly conductive, tunable single-molecule devices in which the molecule is attached to leads by using direct metal-metal contacts. Their novel approach uses light to control the electronic properties of the devices and opens the door to broader use of metal-metal contacts that could facilitate electron transport across the single-molecule device.  The challenge As devices continue to shrink, their electronic ...

LAST 30 PRESS RELEASES:

Nearly 80% of whale sharks in this marine tourism hotspot have human-caused scars

Spider uses trapped fireflies as glowing bait to attract more prey

How AI can build bridges between nations, if diplomats use it wisely

80% of Americans don’t know early-stage prostate cancer often has no symptoms

Researchers engineer ureter tissue from stem cells, paving way for transplantable kidneys

Strong, evidence-based leadership at CDC essential in wake of director’s exit, says SHEA

Birdwatching tourism is booming. Some countries are benefiting, while others are left behind

High protein or Trp diet increases the risk of cancer-associated venous thromboembolism

Risk of a second cancer after early breast cancer is low

Genetic key to why immune responses differ between men and women

Discovery could lead to new treatments for life-threatening allergic reactions

CRF announces TCT 2025 late-breaking clinical trials and science

Ancient DNA reveals farming spread through migration, locals slow to adopt it

Researchers turn mouse scalp transparent to image brain development

New research reveals longevity gains slowing, life expectancy of 100 unlikely

Wheat that makes its own fertilizer

Certain communities of pond plants may increase greenhouse gases

Hormone therapy type matters for memory performance after menopause

Stroke risk highest among Native Hawaiian, Pacific Islander people

Scientists reveal warped protoplanetary discs, reshaping ideas about how planets form

Be it feast or famine, orangutans adapt with flexible diets

Insomnia patients report better sleep when taking cannabis-based medical products

Intrusive distracting thoughts may be associated with anxiety and linked to lower well-being, and occur more often when alone than in company

New crocodile-relative “hypercarnivore” from prehistoric Patagonia was 11.5ft long and weighed 250kg

“Unhappiness hump” in aging may have disappeared worldwide

Breathwork can induce altered states of consciousness linked with changes in brain blood flow

New research makes first broad-spectrum antiviral

Good sleep quality might be key for better mental wellbeing in young adults

One step closer to improving ER+ breast cancer patients’ response to therapy

Scientists reveal the first structure of the complete botulinum neurotoxin complex

[Press-News.org] Cleveland Clinic-led research supports repurposing sildenafil (Viagra) for Alzheimer’s treatment
Large-scale study provides evidence that FDA-approved drug can help protect brain cells from Alzheimer’s disease